
Cheri Beranek
Articles
-
Nov 21, 2024 |
thefastmode.com | Cheri Beranek
At times, low-Earth orbit (LEO) satellite internet can be extremely useful. In the aftermath of Hurricane Helene, for example, many rushed to fund the establishment of free satellite services in areas cut off from internet or phone providers, including the Federal Emergency Management Agency (FEMA).
-
Oct 17, 2024 |
forbes.com | Cheri Beranek
Cheri Beranek, President & CEO of optical-fiber management and connectivity company Clearfield. A 2023 EY National Entrepreneur of the Year. Over the next few years, an estimated $80 billion in government-funded broadband projects is about to hit the ground running.
-
Oct 10, 2024 |
entrepreneur.com | Cheri Beranek
In my 20s, I met the most amazing salesperson: If a prospective buyer liked cigars and cognac, he would show up in cowboy boots with a drink and a smoke — whatever it took to get the order. And he usually did. Still, those behaviors often made their way into the workplace. He got so good at blending in to get what he needed from people that we never knew when he was being authentic or just trying to achieve his own ends.
-
Sep 30, 2024 |
thefastmode.com | Cheri Beranek
When Congress passed the 2021 Infrastructure Investment and Jobs Act (IIJA) that included $42.5 billion for Broadband Equity, Access, and Deployment (BEAD), it had bipartisan support. The next step to enacting that legislation was for government agencies like the FCC and the NTIA to create rules, challenging stakeholders to innovate ways that most effectively and fairly spend this money — a once-in-a-lifetime level of funding that everyone wants to ensure is spent right.
-
Sep 28, 2024 |
wealthinsidermag.com | Cheri Beranek
On Friday, BMO Capital adjusted its price target on shares of Bristol-Myers Squibb Co. (NYSE:), raising it to $53.00 from the previous $48.00, while maintaining a Market Perform rating on the stock. This change follows the approval of COBENFY, a new medication developed by Bristol-Myers Squibb. The approval of COBENFY, which does not carry a boxed warning, is seen as a significant development for the company.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →